Where does UCL Business Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), UCL Business Ltd ranks #3,051 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does UCL Business Ltd hold?

UCL Business Ltd holds 125 US utility patents granted between 2018 and 2025, spanning 68 technology areas.

What is UCL Business Ltd's Innovation Score?

UCL Business Ltd has an Innovation Score of 60.0 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UCL Business Ltd focus on?

UCL Business Ltd's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 72 patents. Grants appear in 68 CPC subclasses total.

Is UCL Business Ltd's patent grant rate increasing or decreasing?

UCL Business Ltd's recent grant velocity is +2400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for UCL Business Ltd's patents?

UCL Business Ltd's patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the UCL Business Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UCL Business Ltd

USPTO PatentsView assignee record - 125 granted patents across 68 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, UCL ranks #3,051 of 49,997 tracked US assignees by granted-patent volume, with 125 patents across 68 technology areas.

#3,051
of 49,997 US assignees by volume: Top 4%
by Innovation Score (60.0/100): 17.2
avg claims per patent: +2400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3051 · Foreign Corporation #3,051 · 125 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 125 grants
TOP-DECILE #3,051/49,997
PHOTO-FINISH SimpliSafe
CPC-WIDE A61K · 68 areas
INNOV-PAR 60.0/100
CLAIMS-RICH 17.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +2400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SimpliSafe, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Biamp Systems · near

60
Morgan State… · near

60
Thermo Fisher… · near

60
UCL Business · this assignee

60
Chemtreat · near

60
3D Lighting… · lowest

7

What this shows UCL's Innovation Score is 60.0/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How UCL's grant cadence moved

Between 2020–2024, UCL Business Ltd received 100 grants versus 4 in 2015–2019 (+2400% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2020 at 29 grants and bottomed in 2018 at 1. Lead class A61K accounts for 57.6% of the portfolio across 68 subclasses. Volume neighbours: Singapore Health Services PTE. Ltd. (#3,047) and ASM Technology Singapore PTE Ltd (#3,055).

UCL's three-year grant acceleration

From 2019–2021 to 2022–2024, UCL Business Ltd moved from 47 to 56 grants (1.19x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #794. See the growth leaderboard.

Singapore Health…

125
SKC

125
Simplisafe

125
Stichting Imec Ne…

125
Université Laval

125
V-nova Internatio…

125
Wm Wrigley Jr

125
UCL Business ◀

125
ASM Technology Si…

124

What this shows UCL holds 125 patents at rank #3,051, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UCL

By rank, the assignees closest to #3,051 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in UCL's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for UCL, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (60 here).

Thermo Fisher Scientific (BREMEN) GMBH 60 Morgan State University 60 Biamp Systems, LLC 60 Chemtreat, Inc. 60

Similar claim depth

Nearest assignees by average claims per patent (17.2 here).

Moog Inc. 17.2 avg Daqri, LLC 17.2 avg Beiersdorf AG 17.2 avg Lemon Inc. 17.2 avg

UCL's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

UCL Business Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	0.8%
2019	3	2.4%
2020	29	23.2%
2021	15	12.0%
2022	14	11.2%
2023	20	16.0%
2024	22	17.6%
2025partial year	21	16.8%

Which technologies does UCL Business Ltd patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 72

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 56

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 44

C07K - Peptides 42

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

C12Y - Enzymes 14

A61B - DIAGNOSIS; SURGERY; Identification 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

G06T - Image Data Processing OR Generation, IN General 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

C07D - Heterocyclic Compounds 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

Top 15 of 68 technology areas

Where it ranks

Overall rank by patents

#3,051

of 49,997 tracked assignees

Innovation Score

60.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

UCL Business Ltd's patent record in context - here's where to go next.

UCL Business Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 57.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,051 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare UCL Business Ltd against Singapore Health Services PTE. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 60.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.